ArticleiScience2026
Ultra short waves alleviate ulcerative colitis via TRPV2 mediated-macrophage polarization.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ultra short wave (USW) therapy, known for its deep tissue penetration in electromagnetic waves, is clinically used to treat local inflammation and alleviate pain, yet its role in intestinal inflammation via macrophage regulation remains unclear. We investigated whether USW exerts non-thermal effects on macrophages to alleviate colitis using dextran sulfate sodium (DSS)-induced mouse models and LPS-stimulated BMDMs/THP-1 cells. Results demonstrated that USW significantly ameliorated intestinal inflammation by directly targeting macrophages, as macrophage depletion completely abrogated its therapeutic effects. Mechanistically, USW induced distinct shifts in intracellular calcium flux and modulated cytokine expression through the TRPV2/CaMKII/Nrf2 signaling pathway. This study confirms that USW alleviates colitis by regulating macrophage polarization and calcium signaling, uncovering a distinct therapeutic pathway and highlighting the potential of non-invasive USW treatment as an effective strategy for improving colitis prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.